Lucidenic Acid D2 – CAS 98665-16-8

Ganoderma lucidum (reishi mushroom) has been traditionally used for increasing energy, improving immunity, and promoting health and longevity. Polysaccharides and triterpenoids are its two main types of compounds and considered to be responsible for its pharmacological activities. Ganoderic acids are the major components of the Ganoderma triterpenes. Lucidenic acids are the second major group of triterpenoids found in the Ganoderma species. The most widely studied pharmacological effect of lucidenic acid D2 (CAS 98665-16-8) is its anti-cancer effect. Lucidenic acid D2 can induce cytotoxicity in different cancer cell lines, including prostate cancer, leukemia, liver cancer, and lung cancer cells. Find the entire collection of Ganoderma triterpenes here.